896 related articles for article (PubMed ID: 30197484)
41. The interreader agreement and validation of contrast-enhanced ultrasound liver imaging reporting and data system.
Li J; Ling W; Chen S; Ma L; Yang L; Lu Q; Luo Y
Eur J Radiol; 2019 Nov; 120():108685. PubMed ID: 31606712
[TBL] [Abstract][Full Text] [Related]
42. Unique portal venous phase imaging discordance between CEUS and MRI: a valuable predictor of intrahepatic cholangiocarcinoma?
Wilson SR; Burrowes DP; Merrill C; Caine BA; Gupta S; Burak KW
Abdom Radiol (NY); 2024 Jan; 49(1):11-20. PubMed ID: 37804423
[TBL] [Abstract][Full Text] [Related]
43. Contrast-Enhanced Ultrasound-Based Nomogram: A Potential Predictor of Individually Postoperative Early Recurrence for Patients With Combined Hepatocellular-Cholangiocarcinoma.
Guo HL; Lu XZ; Hu HT; Ruan SM; Zheng X; Xie XY; Lu MD; Kuang M; Shen SL; Chen LD; Wang W
J Ultrasound Med; 2022 Aug; 41(8):1925-1938. PubMed ID: 34751450
[TBL] [Abstract][Full Text] [Related]
44. Differential diagnosis between hepatic alveolar echinococcosis and intrahepatic cholangiocarcinoma with conventional ultrasound and contrast-enhanced ultrasound.
Wa ZC; Du T; Li XF; Xu HQ; Suo-Ang QC; Chen LD; Hu HT; Wang W; Lu MD
BMC Med Imaging; 2020 Aug; 20(1):101. PubMed ID: 32854653
[TBL] [Abstract][Full Text] [Related]
45. Diagnosis of LI-RADS M lesions on gadoxetate-enhanced MRI: identifying cholangiocarcinoma-containing tumor with serum markers and imaging features.
Jiang H; Song B; Qin Y; Chen J; Xiao D; Ha HI; Liu X; Oloruntoba-Sanders O; Erkanli A; Muir AJ; Bashir MR
Eur Radiol; 2021 Jun; 31(6):3638-3648. PubMed ID: 33245494
[TBL] [Abstract][Full Text] [Related]
46. Differentiation between combined hepatocellular carcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017.
Li CQ; Zheng X; Guo HL; Cheng MQ; Huang Y; Xie XY; Lu MD; Kuang M; Wang W; Chen LD
BMC Med Imaging; 2022 Mar; 22(1):36. PubMed ID: 35241004
[TBL] [Abstract][Full Text] [Related]
47. Using new criteria to improve the differentiation between HCC and non-HCC malignancies: clinical practice and discussion in CEUS LI-RADS 2017.
Zeng D; Xu M; Liang JY; Cheng MQ; Huang H; Pan JM; Huang Y; Tong WJ; Xie XY; Lu MD; Kuang M; Chen LD; Hu HT; Wang W
Radiol Med; 2022 Jan; 127(1):1-10. PubMed ID: 34665430
[TBL] [Abstract][Full Text] [Related]
48. Added-value of ancillary imaging features for differentiating hepatocellular carcinoma from intrahepatic mass-forming cholangiocarcinoma on Gd-BOPTA-enhanced MRI in LI-RADS M.
Zheng W; Huang H; She D; Xiong M; Chen X; Lin X; Cao D
Abdom Radiol (NY); 2022 Mar; 47(3):957-968. PubMed ID: 34964069
[TBL] [Abstract][Full Text] [Related]
49. Differentiation of hepatocellular carcinoma from intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma in high-risk patients matched to MR field strength: diagnostic performance of LI-RADS version 2018.
Zou X; Luo Y; Morelli JN; Hu X; Shen Y; Hu D
Abdom Radiol (NY); 2021 Jul; 46(7):3168-3178. PubMed ID: 33660040
[TBL] [Abstract][Full Text] [Related]
50. Enhancement Patterns of Intrahepatic Cholangiocarcinoma on Contrast-Enhanced Ultrasound: Correlation with Clinicopathologic Findings and Prognosis.
Yuan M; Li R; Zhang Y; Yang L; Zhang X; Tang C; Guo D
Ultrasound Med Biol; 2019 Jan; 45(1):26-34. PubMed ID: 30292461
[TBL] [Abstract][Full Text] [Related]
51. Differentiation of Intrahepatic Cholangiocellular Carcinoma from Hepatocellular Carcinoma in the Cirrhotic Liver Using Contrast-enhanced MR Imaging.
Wengert GJ; Baltzer PAT; Bickel H; Thurner P; Breitenseher J; Lazar M; Pones M; Peck-Radosavljevic M; Hucke F; Ba-Ssalamah A
Acad Radiol; 2017 Dec; 24(12):1491-1500. PubMed ID: 28756085
[TBL] [Abstract][Full Text] [Related]
52. MRI features of combined hepatocellular- cholangiocarcinoma versus mass forming intrahepatic cholangiocarcinoma.
Sammon J; Fischer S; Menezes R; Hosseini-Nik H; Lewis S; Taouli B; Jhaveri K
Cancer Imaging; 2018 Feb; 18(1):8. PubMed ID: 29486800
[TBL] [Abstract][Full Text] [Related]
53. The Radiological Differentiation of Hypervascular Intrahepatic Cholangiocarcinoma from Hepatocellular Carcinoma with a Focus on the CT Value on Multi-phase Enhanced CT.
Sano S; Yamamoto Y; Sugiura T; Okamura Y; Ito T; Ashida R; Ohgi K; Aramaki T; Nakanuma Y; Uesaka K
Anticancer Res; 2018 Sep; 38(9):5505-5512. PubMed ID: 30194209
[TBL] [Abstract][Full Text] [Related]
54. Contrast enhanced ultrasound in mixed hepatocellular cholangiocarcinoma: Case series and review of the literature.
Dong Y; Teufel A; Trojan J; Berzigotti A; Cui XW; Dietrich CF
Dig Liver Dis; 2018 Apr; 50(4):401-407. PubMed ID: 29233685
[TBL] [Abstract][Full Text] [Related]
55. Intrahepatic Cholangiocarcinoma in Patients with Cirrhosis: Differentiation from Hepatocellular Carcinoma by Using Gadoxetic Acid-enhanced MR Imaging and Dynamic CT.
Choi SH; Lee SS; Kim SY; Park SH; Park SH; Kim KM; Hong SM; Yu E; Lee MG
Radiology; 2017 Mar; 282(3):771-781. PubMed ID: 27797675
[TBL] [Abstract][Full Text] [Related]
56. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound.
Vilana R; Forner A; Bianchi L; García-Criado A; Rimola J; de Lope CR; Reig M; Ayuso C; Brú C; Bruix J
Hepatology; 2010 Jun; 51(6):2020-9. PubMed ID: 20512990
[TBL] [Abstract][Full Text] [Related]
57. Tumor size-based validation of contrast-enhanced ultrasound liver imaging reporting and data system (CEUS LI-RADS) 2017 for hepatocellular carcinoma characterizing.
Pan JM; Chen W; Zheng YL; Cheng MQ; Zeng D; Huang H; Huang Y; Xie XY; Lu MD; Kuang M; Hu HT; Chen LD; Wang W
Br J Radiol; 2021 Oct; 94(1126):20201359. PubMed ID: 34545763
[TBL] [Abstract][Full Text] [Related]
58. CEUS and HCC: are the 2008 EFSUMB guidelines still valid or has their wash-out already started?
Giorgio A; Calisti G; Giorgio V
Ultraschall Med; 2011 Jun; 32(3):315-6. PubMed ID: 21667409
[No Abstract] [Full Text] [Related]
59. Different MR features for differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma according to tumor size.
Ni T; Shang XS; Wang WT; Hu XX; Zeng MS; Rao SX
Br J Radiol; 2018 Jul; 91(1088):20180017. PubMed ID: 29791202
[TBL] [Abstract][Full Text] [Related]
60. Contrast-Enhanced Ultrasound in the Diagnosis of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Controversy over the ASSLD Guideline.
Guo LH; Xu HX
Biomed Res Int; 2015; 2015():349172. PubMed ID: 26090401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
